Found 8 matching trials
Study of Extended Release Niacin/Laropiprant on Lipids (0524A-067) PHASE3 This is a 12-Week clinical trial in patients with Primary hypercholesterole...
Show More Location
Multiple Locations
Learn More & Join Trial
To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED) PHASE3 To evaluate the efficacy and safety of ezetimibe/simvastatin and niacin in ...
Show More Location
Multiple Locations
Learn More & Join Trial
MK-0524B Lipid Study (MK-0524B-063) PHASE3 This is a 20-week clinical trial in participants with primary hypercholeste...
Show More Location
Multiple Locations
Learn More & Join Trial
MK0524A Bioequivalence Study (0524A-059) PHASE1 This study will evaluate the definitive bioequivalence of tablets of MK0524...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate the Effects of Extended Release (ER) Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites in Subjects With High Cholesterol (0524A-075)(COMPLETED) PHASE1 The purpose of this study is to evaluate the potential effects of ER niacin...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate the Effects of Laropiprant on the Antiplatelet Effects of Clopidogrel and Aspirin in Combination (MK-0524A-114)(COMPLETED) PHASE1 This is a 3-period study. Periods 1 and 2 will evaluate the effects of mult...
Show More Location
Multiple Locations
Learn More & Join Trial
Extended Niacin/Laropiprant in Patients With Type 2 Diabetes (0524A-069) PHASE3 A study to assess the efficacy and tolerability of ER (Extended Release) ni...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate the Effects of ER Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites (0524A-079)(COMPLETED) PHASE1 The purpose of this study is to evaluate the potential effects of ER niacin...
Show More Location
Multiple Locations
Learn More & Join Trial